RxDoctor Payments Data

Koji Ebersole, MD

Neurological Surgery · Kansas City, KSNPI 1508061425

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Microvention, Inc. at 45.1% of the total. Among neurological surgery clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$123,314in general payments, 2019–2025

Across 158 payments — averaging $780.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$56K
  • Stryker$52K
  • Medical Device Business Services, Inc.$10K
  • Corindus Inc.$1K
  • Siemens Medical Solutions USA, Inc.$1K
  • Johnson & Johnson$793
  • plus $2K from 11 others
$556,270in research payments, 2019–2025

Across 76 payments — averaging $7319.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$339K
  • Balt USA, LLC$112K
  • Microvention, Inc.$61K
  • Medical Device Business Services, Inc.$44K

What the payments were for

  • Consulting fees$38,19831%
  • Speaking & faculty fees$43,41735%
  • Travel & lodging$35,62429%
  • Food & beverage$6,0755%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$123,314 in reported general payments places this provider in the 90th percentile of 63 neurological surgery providers in Kansas.

See all neurological surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$96,741
Medicare patients
165
Services billed
525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate17$252

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →